During the meeting, our team engaged with attendees at our booth, connecting with pathologists, laboratory managers and industry peers. We shared insights into our comprehensive pathology solutions, addressed technical inquiries and discussed how our offerings can support reliable, efficient diagnostic workflows in clinical laboratories.
AREX’s pathology portfolio includes core solutions designed to meet routine and complex diagnostic needs, such as IHC antibodies (raw), tissue-specific antibody series, the AREXVisual® System, micropolymer detection systems, chromogens and supporting ancillaries. These products are developed to deliver consistent, high-quality performance for immunohistochemistry applications.
We sincerely thank all attendees, partners and peers who visited our booth at the 2025 Chinese Pathology Annual Meeting. The event provided a valuable opportunity to strengthen connections with the pathology community, gather feedback from clinical users and align our product development with the evolving needs of diagnostic laboratories across China.
For further information about AREX Biosciences’ pathology solutions, please contact our team directly.
Post time: 2025-04-30 10:24:33
